alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2006224EN.01000801.xml

| 16.9.2006 | EN | Official Journal of the European Union | C 224/8 |
| --- | --- | --- | --- |

16.9.2006

EN

Official Journal of the European Union

C 224/8

---

Judgment of the Court (Second Chamber) of 13 July 2006 (reference for a preliminary ruling from the Gerechtshof te Amsterdam — Netherlands) — Uroplasty BV v Inspecteur van de Belastingdienst — Douanedistrict Rotterdam

(Case C-514/04) (1)

1

(Tariff classification - Sterile flakes of polydimethilsiloxane - Silicone elastomer - Meaning of ‘primary form’ - Medicament - Packaging - Meaning of ‘appliance implanted in the body’)

(2006/C 224/13)

Language of the case: Dutch

Referring court

Gerechtshof te Amsterdam

Parties to the main proceedings

Applicant: Uroplasty BV

Applicant:

Defendant: Inspecteur van de Belastingdienst — Douanedistrict Rotterdam

Defendant:

Re:

Preliminary ruling — Gerechtshof te Amsterdam — Tariff classification of the product Macroplastic implant — Injectable sterile suspension of solid particles of silicone elastomer for the treatment of vesicoureteral (or vesicorenal) reflux

Operative part of the judgment

Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff, as amended by Commission Regulation (EC) No 2388/2000 of 13 October 2000, is to be interpreted as meaning that a product, such as the polydimethilsiloxane, made up of sterile flakes, specially developed and intended only to be implanted in the body for the treatment of a condition and which is packaged at the time of its presentation to customs in 1 kg bags, is to be regarded as an appliance to be implanted in the body which must be classified under heading 9021 of the Combined Nomenclature. Since the purpose of such a product is not to replace an organ but to enable a defective muscle to create connective tissues, it must be classified under subheading 9021 90 90 of the Combined Nomenclature.

---

(1)  OJ C 57, 5.3.2005.

1

---
# C_2007015EN.01000201.xml

| 23.1.2007 | EN | Official Journal of the European Union | C 15/2 |
| --- | --- | --- | --- |

23.1.2007

EN

Official Journal of the European Union

C 15/2

---

Non-opposition to a notified concentration

(Case COMP/M.4146 — GE/BAYER/OSi Europe Business)

(Text with EEA relevance)

(2007/C 15/03)

On 4 May 2006, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32006M4146. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32006M4146. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu)

---
### §2017. Eligibility

The credit and financial services authorized in this subchapter may be made available to persons who are or become stockholders or members of the bank or associations in the district, and who are—

(1) bona fide farmers, ranchers, or producers or harvesters of aquatic products;

(2) persons furnishing to farmers and ranchers farm-related services directly related to their on-farm operating needs; or

(3) owners of rural homes.

(Pub. L. 92–181, title I, §1.9, as added Pub. L. 100–233, title IV, §401, Jan. 6, 1988, 101 Stat. 1626.)

#### **Editorial Notes**

#### Prior Provisions

A prior section 2017, Pub. L. 92–181, title I, §1.9, Dec. 10, 1971, 85 Stat. 586; Pub. L. 96–592, title I, §106, Dec. 24, 1980, 94 Stat. 3438; Pub. L. 100–233, title IV, §426, title VIII, §802(d), Jan. 6, 1988, 101 Stat. 1657, 1710; Pub. L. 100–399, title IV, §412, title VII, §701, Aug. 17, 1988, 102 Stat. 1004, 1006, related to security, prior to the general amendment of this subchapter by Pub. L. 100–233, §401.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date

Pub. L. 100–233, title IV, §401, Jan. 6, 1988, 101 Stat. 1622, provided that this section is effective 6 months after Jan. 6, 1988.
p. 1 

# OAR Box 1778 Prepped byOllie Stewart



# Document

Number: 

# 168 ) II-E-1 9 Docket Number: 

# A-90-0 6

Printed 10/28/2008 9:50:59 AM Sheet 168 of 276P. 2 

# MW W

# • II-E-1 9 CONVERSATIO N RECG- w A<pn>^ | iWfffff 

# TfS&h? TYP E •VISI T Locatio n o fVisit/Conferenct i •CONFERENC E ^ TELEPHON E

Q INCOMIN G ffi OUTGOIN G ROUTIN G NAME/SYMBO L NAM E O F PERSON(S ) CONTACTE D O R I N CONTAC T WIT H YO U 

## /Vw k .TT^UWV J ORGANIZATIO N (Office , dept. . bureau , etc. ) TELEPHON E NO* . 

# f7^^ ° fcevt4-v. •«-> " SUBJEC T. W€-i ? C o -( g y \ - Wi-.yly^rvo'T^ w 

# fc. ?aifi J IN T

SUMMAR Y XcJli U /VW k ov/ o v-foil.vu^ ) -f c Je n



# r-t i^J C \r\)oeL£ict\

gJfe- fg» AW»yUi't^-tv ^ JL u y'^ t \^w\~a U Mark , cyj-lfta-g v\^Xc< > -\-U yJyVvcJl XJaUw-r t ~K> t r^Jai V t~ ° . ^ - ^N-< LV- ( <*• >

* • 

## -* 4 ^_f- -



# \^\J.c*Jkk . tk^Cvx^^t 1 

# ! luJ L 1***- ^ U^lv l (TY V W Wluw^i v-^v - t «-J't*''Vlf . ki-J C -tavNZ^v . i»«ut Wov^o fUrvi ^ 

# •* f k>& . .yl- o k-a-l- L»t,l»lt WM'ti i E- P 1~*J^-^^w t kAw^tk . Al«v k \YJ|;C-^ 4 

# -Hu. t^it ? ^»y V^-(^ Q kso

\+S ~ N Catr^fltft . Jt ^ t^t'"> | ttt U V^k , t^J L •?a>vl?y> N *: t^VTUJct * ew S o o vcv- ra , VO\\'\Q\>(^. . ACTIO N REQUIRE D

NAM E O F PERSO N DOCUMENTIN G CONVERSATIO N ! DAT E 

# \ vy \ K/^

/ 8 6 ACTIO N TAKE N 

# r SIGNATUR E TITL E DAT E 50271-10 1 U.S.G.P.O. : 198 5 -461-275/2020 2 CONVERSATIO N RECOR D OPTIONA L FO« M 27 1 (12-7 6 DEPARTMEN TO P DEFENS E
§ 46.108 IRB functions and operations. ( a ) In order to fulfill the requirements of this policy each IRB shall: ( 1 ) Have access to meeting space and sufficient staff to support the IRB's review and recordkeeping duties;
( 2 ) Prepare and maintain a current list of the IRB members identified by name; earned degrees; representative capacity; indications of experience such as board certifications or licenses sufficient to describe each member's chief anticipated contributions to IRB deliberations; and any employment or other relationship between each member and the institution, for example, full-time employee, part-time employee, member of governing panel or board, stockholder, paid or unpaid consultant;
( 3 ) Establish and follow written procedures for: ( i ) Conducting its initial and continuing review of research and for reporting its findings and actions to the investigator and the institution;
( ii ) Determining which projects require review more often than annually and which projects need verification from sources other than the investigators that no material changes have occurred since previous IRB review; and
( iii ) Ensuring prompt reporting to the IRB of proposed changes in a research activity, and for ensuring that investigators will conduct the research activity in accordance with the terms of the IRB approval until any proposed changes have been reviewed and approved by the IRB, except when necessary to eliminate apparent immediate hazards to the subject.
( 4 ) Establish and follow written procedures for ensuring prompt reporting to the IRB; appropriate institutional officials; the department or agency head; and the Office for Human Research Protections, HHS, or any successor office, or the equivalent office within the appropriate Federal department or agency of ( i ) Any unanticipated problems involving risks to subjects or others or any serious or continuing noncompliance with this policy or the requirements or determinations of the IRB; and
( ii ) Any suspension or termination of IRB approval.
( b ) Except when an expedited review procedure is used (as described in § 46.110), an IRB must review proposed research at convened meetings at which a majority of the members of the IRB are present, including at least one member whose primary concerns are in nonscientific areas. In order for the research to be approved, it shall receive the approval of a majority of those members present at the meeting.
(Approved by the Office of Management and Budget under Control Number 0990-0260)
# C_2007069EN.01001002.xml

| 24.3.2007 | EN | Official Journal of the European Union | C 69/10 |
| --- | --- | --- | --- |

24.3.2007

EN

Official Journal of the European Union

C 69/10

---

Action brought on 5 February 2007 — Commission of the European Communities v Kingdom of Spain

(Case C-50/07)

(2007/C 69/23)

Language of the case: Spanish

Parties

Applicant: Commission of the European Communities (represented by: B. Stromsky and S. Pardo Quintillán, acting as Agents)

Applicant:

Defendant: Kingdom of Spain

Defendant:

Form of order sought

| — | A declaration that, by failing to adopt all the laws, regulations and administrative provisions necessary to comply with Directive 2004/24/EC (1) of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use, the Kingdom of Spain has failed to fulfil its obligations under Article 2 of that directive; |
| --- | --- |

—

A declaration that, by failing to adopt all the laws, regulations and administrative provisions necessary to comply with Directive 2004/24/EC (1) of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use, the Kingdom of Spain has failed to fulfil its obligations under Article 2 of that directive;

1

| — | an order that the Kingdom of Spain should pay the costs. |
| --- | --- |

—

an order that the Kingdom of Spain should pay the costs.

Pleas in law and main arguments

The period prescribed for transposition into domestic law of Directive 2004/24/EC expired on 30 October 2005.

---

(1)  OJ L 136, 2004, p. 85.

1

---
§ 11.501 Judgments in civil actions. ( a ) In all civil cases, judgment shall consist of an order of the court awarding damages to be paid to the injured party, or directing the surrender of certain property to the injured party, or the performance of some other act for the benefit of the injured party, including injunctive relief and declaratory judgments.
( b ) Where the injury inflicted was the result of carelessness of the defendant, the judgment shall fairly compensate the injured party for the loss he or she has suffered.
( c ) Where the injury was deliberately inflicted, the judgment shall impose an additional penalty upon the defendant, which additional penalty may run either in favor of the injured party or in favor of the tribe.
( d ) Where the injury was inflicted as a result of accident, or where both the complainant and the defendant were at fault, the judgment shall compensate the injured party for a reasonable part of the loss he or she has suffered.
( e ) No judgment shall be given on any suit unless the defendant has actually received notice of such suit and ample opportunity to appear in court in his or her defense.
[if !vml]>[endif]>
[if !vml]>[endif]>
You havereached the Federal Depository Library Program Electronic Collection (FDLP/EC)Archive. This archive assures ongoing access to publications in the FDLP/EC.Access to publications in the archive is available through GPO's suite ofcataloging and locator services, including the Catalog of U.S. GovernmentPublications.  Archived copies of publications are retrieved in the eventthat publications are no longer available from the original publishing agencysite. (Historical purposes)
**Title:****NIST standardreference materials.****Price list**** 
SuDoc Number:C 13.48/4-2:
ItemNumber:0248-B(online)
CGPSystem Number:000874904
 
Summer2000
Winter2001
Summer2002
Winter2003
February2004**
Exhibit 32.1

Section 1350 Certifications

In connection with the Quarterly Report on Form 10-Q of Actuate Corporation (the Company) for the period ended June 30, 2010 as filed
with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, the Chief Executive Officer of the Company and the Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge on the date hereof, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 6, 2010



|                                     
|-------------------------------------
|/s/    Peter I.
Cittadini            
|Peter I. Cittadini                   
|President and Chief Executive Officer
|(Principal Executive Officer)        



|                                                             
|-------------------------------------------------------------
|/s/    Daniel A.
Gaudreau                                    
|Daniel A. Gaudreau                                           
|Senior Vice President, Operations
and Chief Financial Officer
|(Principal Financial and Accounting Officer)
###### Editorial Note on Part 900

#### Editorial Note:

Nomenclature changes to part 900 appear at 67 FR 34602, May 15, 2002.

#### § 900.204 Is FTCA the exclusive remedy for a non-medical related tort claim arising out of the performance of a self-determination contract?

Yes. Except as explained in § 900.183(b), no claim may be filed against a self-determination contractor or employee based upon performance of non-medical-related functions under a self-determination contract. Claims of this type must be filed against the United States under FTCA.
# CA2007092EN.01000101.xml

| 27.4.2007 | EN | Official Journal of the European Union | CA 92/1 |
| --- | --- | --- | --- |

27.4.2007

EN

Official Journal of the European Union

CA 92/1

---

PUBLICATION OF A VACANCY NOTICE FOR THE POST OF DIRECTOR OF THE EUROPEAN INSTITUTE FOR GENDER EQUALITY

PUBLICATION OF A VACANCY NOTICE FOR THE POST OF DIRECTOR OF THE EUROPEAN INSTITUTE FOR GENDER EQUALITY

(Grade AD 13)

COM/2007/10049

(2007/C/ 92 A/01)

The European Institute for Gender Equality, which is based in Vilnius, is recruiting a Director.

The Institute's Management Board will appoint the Director from a short-list of applicants selected and proposed by the European Commission. The Director will be appointed as a member of the temporary staff at grade AD 13 pursuant to Article 2a of the Conditions of employment of other servants of the European Communities for a period of five years. That period may be extended once for no more than five years. The Institute and the Commission apply an equal opportunities policy.

Applicants must be nationals of a Member State of the European Union.

The job description, the application form and the instructions to applicants can be downloaded from:

http://ec.europa.eu/dgs/personnel_administration/working_senior_mgt_en.htm

The deadline for receipt of applications is 4 June 2007.

The deadline for receipt of applications is 4 June 2007.

---
**Exhibit
      32.2**








**CERTIFICATION
      OF CHIEF FINANCIAL**


**OFFICER
      REGARDING PERIODIC REPORT CONTAINING**


**FINANCIAL
      STATEMENTS**





I,
      Paul
      E. Martin, the Interim Chief Financial Officer of Renaissance Media Group LLC,
      Renaissance Media (Louisiana) LLC, Renaissance Media (Tennessee) LLC and
      Renaissance Media Capital Corporation (the "Company") in compliance with 18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, hereby certify that, the Company's Quarterly Report on
      Form 10-Q for the period ended September 30, 2005 (the "Report") filed
      with
      the Securities and Exchange Commission:




·
            fully
                complies with the requirements of Section 13(a) of the Securities
                Exchange
                Act of 1934; and


·
            the
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company.





/s/
      Paul E. Martin


Paul
      E.
      Martin


Interim
      Chief Financial Officer


(Principal
      Financial Officer)


November
      10, 2005
-  Home 

# Plan for Approvals Identified for Further Assessment

Plan for Approvals Identified for Further Assessment.pdf (94.39 KB)

*DOT is committed to ensuring that information is available in appropriate alternative formats to meet the requirements of persons who have a disability. If you require an alternative version of files provided on this page, please contact          PHMSA-Accessibility@dot.gov.*
### §497a. Notification required for reduction or consolidation of dual-capable aircraft based in Europe

(a) Notification.—Not less than 90 days before the date on which the Secretary of Defense reduces or consolidates the dual-capable aircraft of the United States that are based in Europe, the Secretary shall submit to the congressional defense committees a notification of such planned reduction or consolidation, including the following:

(1) The reasons for such planned reduction or consolidation.

(2) Any effects of such planned reduction or consolidation on the extended deterrence mission of the United States.

(3) The manner in which the military requirements of the North Atlantic Treaty Organization (NATO) will continue to be met in light of such planned reduction or consolidation.

(4) A statement by the Secretary on the response of NATO to such planned reduction or consolidation.

(5) Whether there is any change in the force posture of the Russian Federation as a result of such planned reduction or consolidation, including with respect to the nonstrategic nuclear weapons of Russia that are within range of the member states of NATO.

(b) Dual-capable Aircraft Defined.—In this section, the term "dual-capable aircraft" means aircraft that can perform both conventional and nuclear missions.

(Added Pub. L. 113–66, div. A, title X, §1051(b)(1), Dec. 26, 2013, 127 Stat. 858.)
QuickLinks
 -- Click here to rapidly navigate through this document











 



 
 

Exhibit 10(u)(u)    
    


 
 

HEWLETT-PACKARD COMPANY
  2000 STOCK PLAN COMMON STOCK PAYMENT AGREEMENT    
    



	 	Director Name:	 	ID:





Grant Date: 


Grant
Price: 


Number
of shares granted: 


Award
Type: 


Plan:
2000 Stock Plan


        THIS
AGREEMENT, as of the Grant Date set forth above between HEWLETT-PACKARD COMPANY, a Delaware corporation ("HP"), and the Director, a director of HP, is entered into as follows: 


 
 

WITNESSETH:    
    


        WHEREAS, HP has established the Hewlett-Packard Company 2000 Stock Plan (the "Plan"), a copy of which has been made available to the Director and is made part
hereof; and 


        WHEREAS,
the Director has elected to receive some or all of his retainer in the form of a Common Stock Payment (as defined in the Plan) under the Plan as hereinafter set forth below; 


        NOW
THEREFORE, the parties hereby agree that in consideration of services rendered and to be rendered, HP grants the Director a Common Stock Payment in the amount of the number of shares
of its $0.01 par value HP common stock (the "Shares") set forth above upon the terms and conditions set forth herein. 


	1.
	The
Shares are granted under and pursuant to the Plan and are subject to each and all of the provisions thereof.



	2.
	The
Shares shall be held in book entry form until the restrictions on the Shares lapse.



	3.
	The
Shares may not be pledged, sold or otherwise assigned until all restrictions pertaining to such shares are terminated.



	4.
	The
Shares will be released on the one-year anniversary of the Grant Date.



	5.
	The
Director agrees to receive stockholder information, including copies of any annual report, proxy and Form 10K, from the investor relations section of HP web site at
www.hp.com. The Director acknowledges that additional copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to HP's
Secretary. 








        IN
WITNESS WHEREOF, the parties have executed this Agreement in duplicate the day and year first above written. 



	

 	
 	

 	

 
	 	 	HEWLETT-PACKARD COMPANY
	

 	
 	
By	

 
	 	 	 	

	 	 	Mark V. Hurd

Chief Executive Officer and President
	

 	
 	

By	

 
	 	 	 	

	 	 	Michael J. Holston

Executive Vice President, General Counsel and Secretary
	
Signed:
                                         
                           	
 	

 	

 













QuickLinks



Exhibit 10(u)(u)


HEWLETT-PACKARD COMPANY 2000 STOCK PLAN COMMON STOCK PAYMENT AGREEMENT

WITNESSETH
### SUBCHAPTER III—ENFORCEMENT PROVISIONS
# C_2007056EN.01000202.xml

| 10.3.2007 | EN | Official Journal of the European Union | C 56/2 |
| --- | --- | --- | --- |

10.3.2007

EN

Official Journal of the European Union

C 56/2

---

Judgment of the Court (First Chamber) of 25 January 2007 — Sumitomo Metal Industries Ltd and Nippon Steel Corp. v Commission of the European Communities

(Joined Cases C-403/04 P and C-405/04 P) (1)

1

(Appeals - Competition - Agreements, decisions and concerted practices - Market in seamless steel tubes - Protection of domestic markets - Burden of proof and production of evidence - Duration of the proceedings before the Court of First Instance)

(2007/C 56/03)

Language of the case: English

Parties

Appellants: Sumitomo Metal Industries Ltd (represented by: C. Vajda QC and G. Sproul and S. Szlezinger, Solicitors) and Nippon Steel Corp (represented by: J.-F. Bellis and K. Van Hove, avocats)

Appellants:

Other parties to the proceedings: JFE Engineering Corp, formerly NKK Corp., JFE Steel Corp., formerly Kawasaki Steel Corp., Commission of the European Communities (represented by: N. Khan and A. Whelan, Agents), EFTA Surveillance Authority

Other parties to the proceedings:

Re:

Appeals against the judgment of the Court of First Instance (Second Chamber) of 8 July 2004 in Joined Cases T-67/00, T-68/00, T-71/00 and T-78/00 JFE Engineering Corp. and Others v Commission partially annulling Commission Decision 2003/382/EC of 8 December 1999 relating to a proceeding under Article 81 of the EC Treaty (Case IV/E-1/35.860-B seamless steel tubes) (notified under document number C(1999) 4154) and reducing the amount of the fine imposed on the applicants.

JFE Engineering Corp. and Others

Commission

Operative part of the judgment

The Court:

| 1. | Dismisses the appeals; |
| --- | --- |

1.

Dismisses the appeals;

| 2. | Orders Sumitomo Metal Industries Ltd to pay the costs in Case C-403/04 P and Nippon Steel Corp. to pay the costs in Case C-405/04 P. |
| --- | --- |

2.

Orders Sumitomo Metal Industries Ltd to pay the costs in Case C-403/04 P and Nippon Steel Corp. to pay the costs in Case C-405/04 P.

---

(1)  OJ C 284, 20.11.2004.

1

---